FINEP
VC Fund
Rio De Janeiro, Brazil
FINEP is a Brazilian investment firm that invests in the areas of science, technology, and more.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries FINEP invests in
Stages FINEP invests in
Countries FINEP invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Grant
- $16k–$5.8M
- Pre-Seed
- $17k–$425k
- Series A
- $187k–$10M
Investment Focus
Industry
- Artificial Intelligence 5 (25%)
- Biotechnology 4 (20%)
- Software 3 (15%)
- Manufacturing 3 (15%)
- Information Technology 3 (15%)
Stage
- Grant 9 (45%)
- Pre-Seed 3 (15%)
- Series A 3 (15%)
- Seed 2 (10%)
- Post-IPO Debt 1 (5%)
Country
- Brazil 15 (75%)
- United States 2 (10%)
- Switzerland 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Marcus Alvarenga
Analyst and Manager
|
Analyst and Manager | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Harmony Baby Nutrition
|
Harmony is a biotechnology startup that creates human breast milk protein-based infant nutrition designed to help human babies thrive. It is the world’s first dairy-free, allergen-free and environmentally friendly infant nutrition. Harmony Baby Nutrition was established in 2018 and is based in Boston, MA. | $5.8M / Grant / Dec 10, 2025 | |
São Martinho
|
São Martinho is a sugarcane processor that provides products that include sugar, ethanol, electricity, by-products, DDGS, and corn oil. It generates electricity from the burning of sugarcane bagasse, ensuring self-sufficiency and the sale of the surplus. | $134.7M / Post-IPO Debt / Aug 12, 2025 | |
Nintx
|
Next Innovative Therapeutics involves advancing therapies to the end of preclinical studies, and Nintx develops therapies targeting biological pathways directly and indirectly through gut microbiome modulation. | $10M / Series A / Dec 13, 2024 | |
|
Nintx
|
Next Innovative Therapeutics involves advancing therapies to the end of preclinical studies, and Nintx develops therapies targeting biological pathways directly and indirectly through gut microbiome modulation. | $2M / Grant / Dec 13, 2024 | |
Datakie.ai
|
AI solutions that accelerate analysis, automate complex tasks, and enhance efficiency in public and corporate management. Datakie offers products such as AutoTaskPilot (a virtual coordinator for intelligent process management) and fiscal analysis solutions powered by ML/NLP-based data extraction technology. | $425.1K / Pre-Seed / Dec 04, 2024 | |
Labsoft Technology
|
Labsoft Technology is providing Software solutions for laboratories, industrial quality and sanitation. | $592.2K / Grant / Nov 05, 2024 | |
Arqgen
|
Arqgen develops generative and AI-based software designed for multi-scale architectural designs. | $2M / Grant / Feb 24, 2024 | |
Ada Metaverse
|
A neuroengineering startup that creates solution for metaverse | $16.6K / Pre-Seed / Aug 01, 2023 | |
Taurus
|
Taurus Holdings, Inc. is a holding corporation that owns some of the most powerful guns brands available on the American market today. Taurus Holdings is owned by the publicly traded Brazilian company Taurus Armas, S.A., which manufactures not only firearms but also a variety of widely distributed consumer and industrial products. TaurusInternational (TIMI) manufactures some Taurus brand rifles in the United States and imports the rest from Taurus Armas. TIMI handles all Taurus branded weapons in the United States, whether imported or manufactured by TIMI.Taurus was established on January 1, 1982 in Bainbridge, Georgia. | $33.5M / Debt Financing / Mar 14, 2023 | |
Moya Aero
|
Moya designs, manufactures, and operates innovative all-electric unmanned aerial vehicles for cargo delivery and precision logistics delivering expressive gains in productivity, emission-free. Overcoming the challenges that limit conventional transportation, Moya's solutions empower the future of logistics sustainable and efficiently. | Grant / Feb 02, 2023 | |
| See all 20 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does FINEP invest in?
FINEP invests primarily in Artificial Intelligence, Biotechnology and Software startups, most often at Grant and Pre-Seed stage. Most of the 20 investments tracked by Shizune back companies in Brazil. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is FINEP's check size?
FINEP typically joins rounds of $16k–$5.8M at Grant, $17k–$425k at Pre-Seed and $187k–$10M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds FINEP participates in.
How do I contact FINEP?
Public channels for FINEP include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at FINEP?
The team at FINEP includes Marcus Alvarenga (Analyst and Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
